Safety [R]Evolution is a Veeva podcast that brings insights from Safety leaders with diverse backgrounds — life sciences organizations, technology and business consulting, CROs, and more. Discussing the importance of modernizing pharmacovigilance to deliver products quickly and safely to patients, each of our guests is interviewed by David Kološić, Director of Veeva Safety Strategy.
Subscribe to Safety [R]Evolution to get new episodes as soon as they are released.
UCB’s Adrian Maynier and Veeva’s Mayuran Croos join David Kološić to discuss how to approach a “big bang” consolidation of 17 siloed safety systems into one unified platform for case processing, reporting, signal detection, and content.
David Kološić speaks with Veeva’s Marius Mortensen about the long-term vision for Veeva Safety; the benefits of starting with a trusted, validated cloud platform; and how a platform approach enables connected data and processes, advanced automation, and AI.
Biomapas’ Martijn van de Leur and Olga Asimaki join David Kološić to discuss the importance of CRO-sponsor partnerships in pharmacovigilance. They also talk about the need for simplification and standardization, progress on automation and AI, and how QPPV’s are adapting to shifting technology.
In Episode 2, Eliquent Life Sciences’ Emma-Jane Brookes and Jamie Portnoff speak with David Kološić about simplifying and standardizing PV technology, harmonizing processes across teams and regions, and driving PV transformation through effective change management.
In our launch episode, David Kološić talks with Sandoz’s Aniket Agarwal about how the right data and technology foundation improves speed and operational efficiency for pharmacovigilance teams. We also discuss the benefits and challenges of automation and AI, and where rapidly evolving technologies will take safety in the future.
Reach out to David Kološić if you would like to join the conversation or have ideas for upcoming episodes. We’d like to hear from you!
See how companies like Merck, UCB, and Biomapas are driving safety transformation with a unified and connected pharmacovigilance solution.
